Finance

Lists
Q3 2026 earnings • in 3 days
See details
HLS:TSE
HLS Therapeutics Inc
4,37 CA$
-0,91%
(-0,040) 1D
9 նոյ, 16:00:00 GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for HLS...
Open
4,50 CA$
High
4,50 CA$
Low
4,34 CA$
Mkt. cap
133,07 մլն
Avg. vol.
78,50 հզր
Volume
14,86 հզր
52-wk high
5,38 CA$
52-wk low
3,56 CA$
EPS
-0,39 CA$
Beta
0,49
Shares outstanding
30,94 մլն
No. of employees
85
Open
4,50 CA$
High
4,50 CA$
Low
4,34 CA$
Mkt. cap
133,07 մլն
Avg. vol.
78,50 հզր
Volume
14,86 հզր
52-wk high
5,38 CA$
52-wk low
3,56 CA$
EPS
-0,39 CA$
Beta
0,49
Shares outstanding
30,94 մլն
No. of employees
85
News stories
From web sources and news partners
About HLS Therapeutics Inc
CEO-
Employees85
Founded2014
Headquarters-
SectorHealth Care
Industry-
Next call 3 օրից
նոյ 12, հնգ, 16:30
Fiscal period
Q3 2026
- / -0,08 $
Revenue / Est. (USD)
- / 14,88 մլն
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
13,51 մլն
15,20 մլն
12,86 մլն
14,67 մլն
Cost of goods sold
3,81 մլն
4,28 մլն
4,19 մլն
4,56 մլն
Cost of revenue
3,81 մլն
4,28 մլն
4,19 մլն
4,56 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,78 մլն
5,21 մլն
5,21 մլն
5,45 մլն
Operating expense
11,08 մլն
10,68 մլն
10,89 մլն
11,27 մլն
Total operating expenses
14,88 մլն
14,96 մլն
15,08 մլն
15,83 մլն
Operating income
-1,37 մլն
237,00 հզր
-2,22 մլն
-1,16 մլն
Other non operating income
-534,00 հզր
-517,00 հզր
-87,00 հզր
-73,00 հզր
EBT including unusual items
-3,94 մլն
-1,98 մլն
-2,30 մլն
-1,01 մլն
EBT excluding unusual items
-3,94 մլն
-1,98 մլն
-2,30 մլն
-1,01 մլն
Income tax expense
-17,00 հզր
-647,00 հզր
2,00 հզր
13,00 հզր
Effective tax rate
0,43%
32,64%
-0,09%
-1,29%
Other operating expenses
-
-
-
-
Net income
-3,92 մլն
-1,34 մլն
-2,30 մլն
-1,02 մլն
Net profit margin
-29,00%
-8,79%
-17,86%
-6,95%
Earnings per share
-0,12
-0,04
-0,07
-0,03
Interest and investment income
24,00 հզր
18,00 հզր
12,00 հզր
4,00 հզր
Interest expense
-2,44 մլն
-897,00 հզր
-801,00 հզր
-748,00 հզր
Net interest expenses
-2,42 մլն
-879,00 հզր
-789,00 հզր
-744,00 հզր
Depreciation and amortization charges
5,51 մլն
5,46 մլն
5,54 մլն
5,53 մլն
EBITDA
4,14 մլն
5,18 մլն
3,32 մլն
4,37 մլն
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google Apps